These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28853295)

  • 1. Influence of cytochrome P450 genotype on the plasma disposition of prochlorperazine metabolites and their relationships with clinical responses in cancer patients.
    Tashiro M; Naito T; Kagawa Y; Kawakami J
    Ann Clin Biochem; 2018 May; 55(3):385-393. PubMed ID: 28853295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genetic and non-genetic factors on clinical responses to prochlorperazine in oxycodone-treated cancer patients.
    Tashiro M; Naito T; Ohnishi K; Kagawa Y; Kawakami J
    Clin Chim Acta; 2014 Feb; 429():175-80. PubMed ID: 24360851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients.
    Yamada T; Kanazawa Y; Aoki Y; Uchida E
    J Nippon Med Sch; 2015; 82(2):100-5. PubMed ID: 25959201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
    Yomiya K; Takei D; Kurosawa H; Kono B
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1037-41. PubMed ID: 23986047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
    Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD
    Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of ondansetron and prochlorperazine for the prevention of nausea and vomiting after tympanoplasty.
    van den Berg AA
    Can J Anaesth; 1996 Sep; 43(9):939-45. PubMed ID: 8874912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
    Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
    N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting.
    Mayhall EA; Gray R; Lopes V; Matteson KA
    Am J Emerg Med; 2015 Jul; 33(7):882-6. PubMed ID: 25921968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia.
    Nagai G; Mihara K; Nakamura A; Suzuki T; Nemoto K; Kagawa S; Ohta I; Arakaki H; Kondo T
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):518-24. PubMed ID: 23066770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buccal prochlorperazine as an antiemetic for day care surgery.
    Patterson KW; Armstrong C; Timon D; O'Toole D; Keane PW
    Ir Med J; 1993; 86(6):186-8. PubMed ID: 8106223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapy.
    Smaglia RA; Parkinson DR; Taylor CD
    Clin Pharm; 1984; 3(1):68-71. PubMed ID: 6365417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers.
    Taylor WB; Bateman DN
    Br J Clin Pharmacol; 1987 Feb; 23(2):137-42. PubMed ID: 3828192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of metoclopramide, prochlorperazine and placebo in prevention of postoperative nausea and vomiting (PONV) following tonsillectomy in young adults.
    Jamil M; Gilani SM; Khan SA
    J Ayub Med Coll Abbottabad; 2005; 17(4):40-4. PubMed ID: 16599033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the relationship between expression of cytochrome P450 enzymes and gefitinib pharmacokinetics.
    Swaisland HC; Cantarini MV; Fuhr R; Holt A
    Clin Pharmacokinet; 2006; 45(6):633-44. PubMed ID: 16719544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms.
    Akamine Y; Sugawara-Kikuchi Y; Uno T; Shimizu T; Miura M
    Ann Clin Biochem; 2017 Nov; 54(6):677-685. PubMed ID: 27932669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route.
    Finn A; Collins J; Voyksner R; Lindley C
    J Clin Pharmacol; 2005 Dec; 45(12):1383-90. PubMed ID: 16291713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
    Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
    Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cytochrome P450 (CYP) 3A5 polymorphisms on the pharmacokinetics of lansoprazole enantiomers in CYP2C19 extensive metaboliser renal transplant recipients.
    Miura M; Inoue K; Satoh S; Itoh Y; Kagaya H; Tada H; Tanaka Y; Habuchi T; Suzuki T
    Clin Drug Investig; 2007; 27(4):251-8. PubMed ID: 17358097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels.
    Katz DA; Grimm DR; Cassar SC; Gentile MC; Ye X; Rieser MJ; Gordon EF; Polzin JE; Gustavson LE; Driscoll RM; O'dea RF; Williams LA; Bukofzer S
    Clin Pharmacol Ther; 2004 Jun; 75(6):516-28. PubMed ID: 15179406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.